Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs

Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs

The impact of disease-modifying therapies (DMTs) on the immune response to coronavirus disease-2019 (COVID-19) vaccines in persons with multiple sclerosis (pwMS) needs further elucidation. We investigated BNT162b2 mRNA COVID-19 vaccine effects concerning antibody seroconversion, inflammatory mediato...

Full description

Bibliographic Details
Main Authors: Valentina Mazziotti, Francesco Crescenzo, Agnese Tamanti, Caterina Dapor, Stefano Ziccardi, Maddalena Guandalini, Annalisa Colombi, Valentina Camera, Angela Peloso, Francesco Pezzini, Ermanna Turano, Damiano Marastoni, Massimiliano Calabrese
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Biomedicines
Subjects:
multiple sclerosis
disease-modifying therapies
COVID-19
vaccination
seroconversion
cellular immune response
Online Access:https://www.mdpi.com/2227-9059/10/12/3034

Internet

https://www.mdpi.com/2227-9059/10/12/3034

Similar Items